Nouryon, Ineos break ground
Nouryon and Ineos Nitriles have broken ground on new facilities that will be built at the latter’s site in Cologne, Germany, and completed in 2021 or 2022.
CABB goes digital on rail cars
As part of a digitalisation process, the CABB Group is currently fitting GPS devices to all of the 200 rail tank cars and tank containers it hires to transport monochloroacetic acid (MCA). This should be complete by June, the company said.
Evotec in ‘Pan-TB’ collaboration
Drug discovery firm Evotec, owner of the API manufacturer Aptuit, is a member of the Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration, which was launched formally on 27 February. This will aim to transform global action on TB, which causes more deaths than any other infectious disease, with 10 million new cases and 1.5 million deaths recorded in 2018.
CPhI Japan postponed due to coronavirus
Organisers UBM Japan and Informa Markets have announced that CPhI Japan 2020 has been postponed “as a result of the latest news concerning Novel Coronavirus”.
Sanofi to establish API player
Big Pharma giant Sanofi has announced plans to create a stand-alone company dedicated to the production and marketing of APIs to third parties.
ECHA checking more dossiers
The European Chemicals Agency (ECHA) has revealed that it conducted 301 in-depth checks on almost 3,000 REACH registration dossiers in 2019, covering 274 unique chemicals.
Non-compliance on the rise, says CEFIC
CEFIC has reported that there were 1,468 instances of chemicals in consumer products that were not in compliance with regulations in 2019, 24% up on 2018.
